Theme 10 - Disease Stratification and Phenotyping of Patients

Acknowledgments

We would like to acknowledge the Macquarie University Neurodegenerative Disease Biobank for provision of patient samples and related clinical data.

Acknowledgements

We thank the pALS who participated in VITALITY-ALS and their families for their contributions to the trial.

Acknowledgements

We would like to thank patients for taking part in the study.

Acknowledgements

We are grateful to the families who contributed with their time on partaking in our study.

Acknowledgements

Health Research Board, Research Motor Neurone (www.mnd.ie). Thanks to participants.

Acknowledgements

We thank all individuals who took part in the study and MND and Me, FightMND, The Honda Foundation, and Wesley Medical Research for funding support.

Acknowledgments

We wish to acknowledge all individuals who contributed measures of activity.

Acknowledgements

Thank you to all patients, family members, and staff involved in the collection of the ALS Biomarkers Study data.

Acknowledgments

The authors thank Irene Brody, VMD, PhD of p-value communications, Cedar Knolls, NJ, USA, for providing medical writing support. Editorial support was also provided by p-value communications.